Manuka honey could boost CAUTI prevention

Manuka honey is a monofloral honey made from the nectar of the manuka tree. The honey, commonly sold as an alternative medicine, can reduce the growth of bacterial biofilms, which could help prevent catheter-associated urinary tract infections, according to a new study published in the Journal of Clinical Pathology.

Advertisement

Bacterial biofilms are resilient microbes known to accrue in medical devices like urinary catheters. Among urinary tract infections that occur in hospitals, 75 percent are linked to catheter use, according to the CDC.

For the study, researchers cultured strains Escherichia coli and Proteus mirabilis bacteria — the two bacteria strains responsible for the majority of CAUTIs — in a laboratory setting. Researchers then treated honey with distilled water at different levels of dilution and assigned the samples different levels of strength. The different honey solutions were then added to the bacteria and sealed for 24, 48 and 72 hours.

Results indicated that manuka honey significantly reduced the bacteria’s stickiness, thereby curbing its ability to form biofilm. At the weakest level (3.3 percent), the solution reduced stickiness by 35 percent after 48 hours. The greatest effect was seen after three days at the highest level (16.7 percent), which reduced bacterial stickiness by 77 percent.

“We have been able to demonstrate that diluted honey is potentially a useful agent for reducing biofilm formation on indwelling plastic devices such as urinary catheters,” said Bashir Lwaleed, PhD, associate professor with the University of Southampton in the United Kingdom and one of the study’s authors. “We hope that these results may offer an alternative way of preventing such infections. We believe that patients might also benefit from honey’s anti-inflammatory properties, which are generally stronger in dark honeys, such as Manuka and that antibacterial resistance is unlikely to be a factor when honey is used.”

More articles on infection control: 
CDC, dialysis organizations partner to reduce bloodstream infections 
All 9 heater-cooler devices at UW Medical Center test positive for Legionella: 6 things to know 
New testing device reduces infection identification, antibiotic resistance screening time to just 4 hours

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.